Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label previous answer version answering member constituency answering member printed answering member label
tabling member	label

Search

1536731

registered interest
date	27/10/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Prescription Drugs: Prices
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, with reference to the CMA's press release entitled CMA fines pharma firm over pricing of crucial thyroid drug, published on 29 July 2022, what steps he is taking to prevent extreme price gouging; and if he will make an assessment of the potential merits of including generic drugs in the NHS Voluntary Scheme for Branded Medicines Pricing and Access.
tabling member constituency	Newcastle upon Tyne Central
tabling member printed	Chi Onwurah
uin	72985
answer	answer is ministerial correction date of answer 01/11/2022 answer text <p>The costs of branded medicines are controlled by the Voluntary Scheme for Branded Medicines Pricing and Access (VPAS) and the statutory scheme for branded medicines. For unbranded generic medicines, the Department encourages competition between suppliers to maintain lower prices. In primary care, community pharmacies are incentivised to source products at the lowest possible cost and in secondary care, competitive tenders ensure value-for-money to the National Health Service.</p><p> </p><p>Where competition does not achieve these aims, the Department alerts the Competition and Markets Authority (CMA). Where companies are found by the CMA to be in breach of competition law, the Department considers seeking damages.</p> answering member constituency Colchester answering member printed Will Quince question first answered 01/11/2022 17:33:44 answering member 4423 label Biography information for Will Quince
tabling member	4124 label Biography information for Chi Onwurah

1536554

registered interest
date	26/10/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Voluntary Scheme for Branded Medicines Pricing and Access
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what (a) meetings and (b) discussions he has with representatives of (i) pharmaceutical and (ii) life science companies on changes to the Voluntary Scheme for Branded Medicines Pricing and Access (VPAS); and what assessment he has made of the potential impact of changes to the VPAS rebate rate on foreign direct investment into UK life science R&D.
tabling member constituency	Newcastle upon Tyne Central
tabling member printed	Chi Onwurah
uin	72255
answer	answer is ministerial correction date of answer 03/11/2022 answer text <p>Ministerial meetings are published on GOV.UK at the following link:</p><p> </p><p><a href="https://www.gov.uk/government/collections/ministerial-gifts-hospitality-overseas-travel-and-meetings#2022" target="_blank">https://www.gov.uk/government/collections/ministerial-gifts-hospitality-overseas-travel-and-meetings#2022</a></p><p> </p><p>No specific assessment of the potential impact of changes to the Voluntary Scheme for Branded Medicines Pricing and Access rebate rate has been made. Changes to payment percentages reflects the Scheme working as intended to adjust for increased sales of branded medicines to the National Health Service. This will result in payment percentages at the rates projected when the Scheme was agreed with industry.</p> answering member constituency Colchester answering member printed Will Quince question first answered 03/11/2022 18:15:17 answering member 4423 label Biography information for Will Quince previous answer version 29183 answering member constituency Colchester answering member printed Will Quince answering member 4423 label Biography information for Will Quince
tabling member	4124 label Biography information for Chi Onwurah

1536556

registered interest
date	26/10/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Life Expectancy: Newcastle upon Tyne
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the implications for her policies of trends in the level of healthy life expectancy in Newcastle.
tabling member constituency	Newcastle upon Tyne Central
tabling member printed	Chi Onwurah
uin	72256
answer	answer is ministerial correction date of answer 03/11/2022 answer text <p>No specific assessment has been made.</p> answering member constituency Harborough answering member printed Neil O'Brien question first answered 03/11/2022 17:49:51 answering member 4679 label Biography information for Neil O'Brien
tabling member	4124 label Biography information for Chi Onwurah

1536557

registered interest
date	26/10/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Eating Disorders: Newcastle upon Tyne
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps her Department is taking to help support young people with eating disorders in Newcastle.
tabling member constituency	Newcastle upon Tyne Central
tabling member printed	Chi Onwurah
uin	72257
answer	answer is ministerial correction date of answer 02/11/2022 answer text <p>In September we announced ‘Our plan for patients’, which outlines how we will increase access to National Health Service mental health and eating disorder services, including in Newcastle. Through the NHS Long Term Plan, we are investing an additional £2.3 billion a year by 2023/24 to expand NHS mental health and eating disorder services for adults, children and young people in England, including in Newcastle.</p><p>We will invest approximately £1 billion in community mental health care for adults with severe mental illness. including eating disorders, by 2023/24 and an additional £53 million per year in children and young people's community eating disorder services to increase capacity in the 70 community eating disorder teams.</p> answering member constituency Lewes answering member printed Maria Caulfield grouped question UIN 72259 question first answered 02/11/2022 13:15:28 answering member 4492 label Biography information for Maria Caulfield
tabling member	4124 label Biography information for Chi Onwurah

1536559

registered interest
date	26/10/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Mental Health Services: Newcastle upon Tyne
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to help support the (a) recruitment and (b) retention of mental health specialists in Newcastle.
tabling member constituency	Newcastle upon Tyne Central
tabling member printed	Chi Onwurah
uin	72259
answer	answer is ministerial correction date of answer 02/11/2022 answer text <p>In September we announced ‘Our plan for patients’, which outlines how we will increase access to National Health Service mental health and eating disorder services, including in Newcastle. Through the NHS Long Term Plan, we are investing an additional £2.3 billion a year by 2023/24 to expand NHS mental health and eating disorder services for adults, children and young people in England, including in Newcastle.</p><p>We will invest approximately £1 billion in community mental health care for adults with severe mental illness. including eating disorders, by 2023/24 and an additional £53 million per year in children and young people's community eating disorder services to increase capacity in the 70 community eating disorder teams.</p> answering member constituency Lewes answering member printed Maria Caulfield grouped question UIN 72257 question first answered 02/11/2022 13:15:28 answering member 4492 label Biography information for Maria Caulfield
tabling member	4124 label Biography information for Chi Onwurah

1536560

registered interest
date	26/10/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Dental Services: Newcastle upon Tyne
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how many children under the age of (a) four and (b) 11 were admitted to hospital for a tooth extraction due to decay in Newcastle in each of the last five years.
tabling member constituency	Newcastle upon Tyne Central
tabling member printed	Chi Onwurah
uin	72260
answer	answer is ministerial correction date of answer 31/10/2022 answer text <p>This information is not held in the format requested.</p> answering member constituency Colchester answering member printed Will Quince grouped question UIN 72370 72423 72496 question first answered 31/10/2022 10:12:36 answering member 4423 label Biography information for Will Quince
tabling member	4124 label Biography information for Chi Onwurah

1524730

registered interest
date	20/10/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Voluntary Scheme for Branded Medicines Pricing and Access
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what recent assessment he has made of the potential impact of changes in the 2019 Voluntary Scheme for Branded Medicines Pricing and Access rebate rate on foreign direct investment into UK life science R&D.
tabling member constituency	Newcastle upon Tyne Central
tabling member printed	Chi Onwurah
uin	67898
answer	answer is ministerial correction date of answer 27/10/2022 answer text <p>No recent assessment has been made. Changes to payment percentages reflects the Scheme working as intended to adjust for increased sales of branded medicines to the National Health Service. This will result in payment percentages at rates projected when the Scheme was agreed with industry.</p> answering member constituency Colchester answering member printed Will Quince question first answered 27/10/2022 11:58:40 answering member 4423 label Biography information for Will Quince previous answer version 27495 answering member constituency Newark answering member printed Robert Jenrick answering member 4320
tabling member	4124 label Biography information for Chi Onwurah

1524731

registered interest
date	20/10/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Voluntary Scheme for Branded Medicines Pricing and Access
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what recent discussions she has with representatives of (a) pharmaceutical and (b) life science companies on changes in the 2019 Voluntary Scheme for Branded Medicines Pricing and Access rebate rate.
tabling member constituency	Newcastle upon Tyne Central
tabling member printed	Chi Onwurah
uin	67899
answer	answer is ministerial correction date of answer 01/11/2022 answer text <p>The Department’s Ministerial meetings are published on GOV.UK at the following link:</p><p> </p><p><a href="https://www.gov.uk/government/collections/ministerial-gifts-hospitality-overseas-travel-and-meetings#2022" target="_blank">https://www.gov.uk/government/collections/ministerial-gifts-hospitality-overseas-travel-and-meetings#2022</a></p> answering member constituency Colchester answering member printed Will Quince question first answered 01/11/2022 12:01:27 answering member 4423 label Biography information for Will Quince previous answer version 27496 answering member constituency Newark answering member printed Robert Jenrick answering member 4320
tabling member	4124 label Biography information for Chi Onwurah

1523884

registered interest
date	18/10/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Gastrointestinal System: Surgery
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 22 September 2022 to Question 49137 on Gastrointestinal System: Surgery, whether her Department has made an estimate of the number of patients living with (a) colostomy, (b) ileostomy and (c) urostomy following their operation.
tabling member constituency	Newcastle upon Tyne Central
tabling member printed	Chi Onwurah
uin	65758
answer	answer is ministerial correction date of answer 27/10/2022 answer text <p>This information is not held in the format requested.</p> answering member constituency Colchester answering member printed Will Quince question first answered 27/10/2022 13:13:41 answering member 4423 label Biography information for Will Quince previous answer version 26731 answering member constituency Newark answering member printed Robert Jenrick answering member 4320
tabling member	4124 label Biography information for Chi Onwurah

1523886

registered interest
date	18/10/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, with reference to the regulatory approval of covid-19 vaccine Nuvaxovid, what plans she has for the usage of this vaccine as (a) a covid-19 booster vaccination or (b) other uses.
tabling member constituency	Newcastle upon Tyne Central
tabling member printed	Chi Onwurah
uin	65759
answer	answer is ministerial correction date of answer 03/11/2022 answer text <p>On 3 February 2022, the Medicines and Healthcare products Regulatory Agency approved Nuvaxovid for use as a COVID-19 primary course vaccination. The Government accepted advice from the Joint Committee on Vaccination and Immunisation (JCVI) that in exceptional circumstances, Nuvaxovid may be used when no clinically suitable United Kingdom-approved COVID-19 vaccine alternative is available. The JCVI’s advice allows its use in either COVID-19 primary course vaccination or off-label as a COVID-19 booster dose. In line with the JCVI’s advice, the Nuvaxovid vaccine is the current alternative for those who are clinically intolerant to and are unable to receive the COVID-19 mRNA vaccines manufactured by Pfizer and Moderna. Deployment of Nuvaxovid began on 28 September 2022.</p> answering member constituency Harborough answering member printed Neil O'Brien question first answered 03/11/2022 16:11:36 answering member 4679 label Biography information for Neil O'Brien previous answer version 25935 answering member constituency Sleaford and North Hykeham answering member printed Dr Caroline Johnson answering member 4592
tabling member	4124 label Biography information for Chi Onwurah